Published in Am J Clin Nutr on December 01, 2004
Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev (2008) 3.12
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A (2010) 2.19
Probiotics and immunity. J Gastroenterol (2009) 1.79
A key role of dendritic cells in probiotic functionality. PLoS One (2007) 1.73
Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One (2010) 1.56
Feeding our immune system: impact on metabolism. Clin Dev Immunol (2008) 1.42
Retracted Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings. Biomed Res Int (2013) 1.39
Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol (2008) 1.21
Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS One (2012) 1.20
Molecular definition of vaginal microbiota in East African commercial sex workers. Appl Environ Microbiol (2011) 1.13
Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol (2007) 1.10
Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients (2013) 1.08
Promising immunomodulatory effects of selected strains of dairy propionibacteria as evidenced in vitro and in vivo. Appl Environ Microbiol (2010) 1.06
Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin Vaccine Immunol (2008) 1.05
Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol (2010) 1.01
L. plantarum, L. salivarius, and L. lactis attenuate Th2 responses and increase Treg frequencies in healthy mice in a strain dependent manner. PLoS One (2012) 0.96
Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. J Inflamm (Lond) (2008) 0.96
Do you have a probiotic in your future? Microbes Infect (2008) 0.95
Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol (2006) 0.93
Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin Vaccine Immunol (2011) 0.92
Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One (2008) 0.92
Effect of micronutrient and probiotic fortified yogurt on immune-function of anti-retroviral therapy naive HIV patients. Nutrients (2011) 0.88
The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry. Int J Inflam (2012) 0.87
Immunomodulatory effects of a probiotic drink containing Lactobacillus casei Shirota in healthy older volunteers. Eur J Nutr (2013) 0.87
Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice. Arthritis Rheumatol (2016) 0.87
Micronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression. Nutrients (2010) 0.85
Probiotic modulation of dendritic cell function is influenced by ageing. Immunobiology (2013) 0.84
The role of probiotics in inflammatory bowel disease. Dig Dis Sci (2007) 0.82
Dietary Lactobacillus rhamnosus GG Supplementation Improves the Mucosal Barrier Function in the Intestine of Weaned Piglets Challenged by Porcine Rotavirus. PLoS One (2016) 0.81
Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol (2012) 0.81
Bugs & us: the role of the gut in autoimmunity. Indian J Med Res (2013) 0.81
Histone deacetylase inhibition and dietary short-chain Fatty acids. ISRN Allergy (2011) 0.80
Impact of lactic Acid bacteria on dendritic cells from allergic patients in an experimental model of intestinal epithelium. J Biomed Biotechnol (2007) 0.79
Genetically Modified Lactococcus lactis for Delivery of Human Interleukin-10 to Dendritic Cells. Gastroenterol Res Pract (2011) 0.79
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol (2016) 0.78
Probiotics and small bowel mucosa: Molecular aspects of their interactions. Genes Nutr (2006) 0.77
Food-producing animals and their health in relation to human health. Microb Ecol Health Dis (2015) 0.77
Prokaryotes Versus Eukaryotes: Who is Hosting Whom? Front Vet Sci (2014) 0.75
Probiotic Lactobacilli Modulate Staphylococcus aureus-Induced Activation of Conventional and Unconventional T cells and NK Cells. Front Immunol (2016) 0.75
The Soil Bacterium Methylococcus capsulatus Bath Interacts with Human Dendritic Cells to Modulate Immune Function. Front Microbiol (2017) 0.75
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet (2008) 10.47
Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med (2005) 5.36
Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med (Berl) (2005) 1.54
Building for big pharma. Nat Biotechnol (2013) 1.53
IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. Ann Neurol (2011) 1.53
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut (2010) 1.53
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders. Hum Gene Ther (2009) 1.37
Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. Blood (2005) 1.34
Endoscopic trimodal imaging detects colonic neoplasia as well as standard video endoscopy. Gastroenterology (2011) 1.31
Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency. Atheroscler Suppl (2010) 1.22
Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis. Eur J Immunol (2002) 1.04
Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling. Endocrinology (2006) 1.00
Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapy. Inflamm Bowel Dis (2011) 0.99
IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. J Immunol (2002) 0.99
Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease. J Immunol (2005) 0.98
Apolipoprotein B knockdown by AAV-delivered shRNA lowers plasma cholesterol in mice. Mol Ther (2011) 0.96
Biological therapies in inflammatory bowel disease: top-down or bottom-up? Curr Opin Gastroenterol (2007) 0.94
Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol (2011) 0.91
Embedding siRNA sequences targeting apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacy. Mol Ther (2012) 0.86
The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy. J Crohns Colitis (2012) 0.84
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. Br J Clin Pharmacol (2014) 0.84
Inflammatory signal transduction in Crohn's disease and novel therapeutic approaches. Biochem Pharmacol (2002) 0.83
Galectins in atherosclerotic disease. Trends Cardiovasc Med (2009) 0.82
Reducing colorectal anastomotic leakage with tissue adhesive in experimental inflammatory bowel disease. Inflamm Bowel Dis (2015) 0.81
Biological therapy in the management of recent-onset Crohn's disease: why, when and how? Drugs (2006) 0.80
Optimization and comparison of knockdown efficacy between polymerase II expressed shRNA and artificial miRNA targeting luciferase and Apolipoprotein B100. BMC Biotechnol (2012) 0.79
Regulatory T cells as potential targets for immunotherapy in inflammatory bowel disease. Immunotherapy (2010) 0.78
Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling. Biotechnol Bioeng (2014) 0.78
Osteoblast adhesion dynamics: a possible role for ROS and LMW-PTP. J Cell Biochem (2014) 0.77
A role for STAT5 in steroid-resistant UC? Inflamm Bowel Dis (2006) 0.77
Mesalazine in left-sided ulcerative colitis: efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing. J Crohns Colitis (2011) 0.77
Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence. Gastrointest Endosc (2008) 0.76
Erratum: Community crystal gazing. Nat Biotechnol (2016) 0.75
Discussion on predictors of response to infliximab in patients with Crohn's disease. Gastroenterology (2003) 0.75
Clostridial Gas Gangrene of the Abdominal Wall After Laparoscopic Cholecystectomy: A Case Report and Review. Surg Laparosc Endosc Percutan Tech (2016) 0.75